@article{MAP11070,
author = {Katherine Egan and Aoife Courtney and Hannah Hession and Joseph Morris and Therese Coleman and Czara Kennedy and Aimee Brennan and Donal O’Shea and Andrew Hogan and Naomi Fearon and Waqas Butt and Lindsey Clarke and Omar El-Sherif and Helen Heneghan},
title = {AB103. SOH26AB_0380. The impact of bariatric surgery on histologically confirmed metabolic dysfunction-associated steatotic liver disease (MASLD) seen on paired liver biopsies},
journal = {Mesentery and Peritoneum},
volume = {10},
number = {0},
year = {2026},
keywords = {},
abstract = {Liver biopsy is the gold-standard investigation for metabolic dysfunction-associated steatotic liver disease (MASLD). However, it is not routinely performed to assess response to therapy, given its invasiveness and risks. Although multiple non-invasive tests have been identified, none have proven equal or superior to liver biopsy. The true histological improvement of MASLD following bariatric surgery is therefore unclear. This study aimed to characterise the impact of bariatric surgery on histologically confirmed MASLD.},
issn = {2616-2725}, url = {https://map.amegroups.org/article/view/11070}
}